[go: up one dir, main page]

AR060905A1 - Composicion fotodinamica en forma de espuma y escleroterapia - Google Patents

Composicion fotodinamica en forma de espuma y escleroterapia

Info

Publication number
AR060905A1
AR060905A1 ARP070102057A ARP070102057A AR060905A1 AR 060905 A1 AR060905 A1 AR 060905A1 AR P070102057 A ARP070102057 A AR P070102057A AR P070102057 A ARP070102057 A AR P070102057A AR 060905 A1 AR060905 A1 AR 060905A1
Authority
AR
Argentina
Prior art keywords
photodynamic
composition
photosensitizer
sclerosis
foam
Prior art date
Application number
ARP070102057A
Other languages
English (en)
Original Assignee
Ceramoptec Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceramoptec Ind Inc filed Critical Ceramoptec Ind Inc
Publication of AR060905A1 publication Critical patent/AR060905A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N2005/0602Apparatus for use inside the body for treatment of blood vessels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Radiation-Therapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Reivindicacion 1: Un método para tratamientos fotonicos in vivo de estructuras vasculares que utiliza una fuente lumínica y una composicion de esclerosis fotodinámica, que comprende los pasos de: a) identificar una o más venas en un área de tratamiento; b) introducir una composicion de esclerosis fotodinámica en dichas una o más venas; c) aguardar un tiempo suficiente para permitir que dicha composicion de esclerosis fotodinámica interactue con dichas una o más venas; y d) aplicar radiacion a partir de una fuente lumínica apropiada, emitiendo una longitud de onda de activacion absorbida por dicha composicion, a dicha área de tratamiento durante un tiempo suficiente para activar un fotosensibilizador en dicha composicion. Reivindicacion 8: Una composicion fotodinámica para utilizar en un método in vivo tal como el de la reivindicacion 1, que comprende: a) una espuma; y b) un fotosensibilizador o un precursor de fotosensibilizador. Reivindicacion 10: La composicion fotodinámica de acuerdo con la reivindicacion 9, donde dicha espuma para esclerosis comprende un detergente y una solucion de glucosa (solucion de glucosa). Reivindicacion 11: La composicion fotodinámica de acuerdo con la reivindicacion 10, donde dicho detergente es polidodecanol. Reivindicacion 12: La composicion fotodinámica de acuerdo con la reivindicacion 8, donde dicho fotosensibilizador o precursor fotosensibilizador es temoporfina.
ARP070102057A 2006-05-11 2007-05-11 Composicion fotodinamica en forma de espuma y escleroterapia AR060905A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79950906P 2006-05-11 2006-05-11
US11/800,400 US20080275432A1 (en) 2006-05-11 2007-05-04 Photodynamic foam composition and sclerosis treatment

Publications (1)

Publication Number Publication Date
AR060905A1 true AR060905A1 (es) 2008-07-23

Family

ID=38694417

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102057A AR060905A1 (es) 2006-05-11 2007-05-11 Composicion fotodinamica en forma de espuma y escleroterapia

Country Status (4)

Country Link
US (2) US20080275432A1 (es)
EP (1) EP2026878A4 (es)
AR (1) AR060905A1 (es)
WO (1) WO2007133525A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129712A1 (en) * 2005-12-01 2007-06-07 Ceramoptec Industries, Inc. Benign prostate hyperplasia treatment using photosensitizer and laser ablation
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US20090326435A1 (en) * 2006-05-02 2009-12-31 Green Medical, Inc. Systems and methods for treating superficial venous malformations like varicose or spider veins
US20070299431A1 (en) * 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
WO2009135081A2 (en) * 2008-04-30 2009-11-05 Board Of Regents, The University Of Texas System Integrated patient bed system
US8838211B2 (en) * 2008-04-30 2014-09-16 Board Of Regents, The University Of Texas System Multi-wavelength diagnostic imager
US9585667B2 (en) 2010-11-15 2017-03-07 Vascular Insights Llc Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein
US20120109191A1 (en) * 2011-12-13 2012-05-03 Vascular Insights Llc Adhesive-based varicose vein treatment
US12036334B2 (en) * 2014-03-28 2024-07-16 Swiss Vx Venentherapie Und Forschung Gmbh Compositions and devices for sclerotherapy using light hardening glues
KR102083503B1 (ko) * 2018-05-31 2020-03-02 서울대학교산학협력단 낭성 질환을 예방 또는 치료하기 위한 약학적 조성물, 키트, 및 이를 이용한 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5533508A (en) * 1991-10-31 1996-07-09 Pdt Systems, Inc. Vivo dosimeter for photodynamic therapy
US5665332A (en) * 1994-03-28 1997-09-09 Oralcare Systems, Inc. System for delivering foams containing medicaments
US5531739A (en) * 1994-09-23 1996-07-02 Coherent, Inc. Method of treating veins
US5829448A (en) * 1996-10-30 1998-11-03 Photogen, Inc. Method for improved selectivity in photo-activation of molecular agents
US7390668B2 (en) * 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US6616451B1 (en) * 1997-06-20 2003-09-09 Biolase Technology, Inc. Electromagnetic radiation emitting toothbrush and dentifrice system
GB9912356D0 (en) * 1999-05-26 1999-07-28 Btg Int Ltd Generation of microfoam
US6200332B1 (en) * 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
AU2002327180A1 (en) * 2001-06-04 2003-01-21 The General Hospital Corporation Detection and therapy of vulnerable plaque with photodynamic compounds
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
WO2004110255A2 (en) * 2003-06-09 2004-12-23 Gang Zheng Antineoplastic agents targeted via glut transporters
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
EP1881801A4 (en) * 2005-05-18 2014-04-02 Biolase Inc ELECTROMAGNETIC RADIATION PUBLISHING TOOTHBRUSH AND TOOTHPASTE SYSTEM

Also Published As

Publication number Publication date
EP2026878A4 (en) 2010-12-08
US20080275432A1 (en) 2008-11-06
WO2007133525A3 (en) 2008-12-18
WO2007133525A2 (en) 2007-11-22
EP2026878A2 (en) 2009-02-25
US20090163849A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
AR060905A1 (es) Composicion fotodinamica en forma de espuma y escleroterapia
USD581057S1 (en) Ankle support
RU2015113595A (ru) Комбинация хромофоров для биофотонных применений
MX2012012034A (es) Dispositivo de iluminacion frontal que comprende una guia de luz a base de pelicula.
AR120961A2 (es) Método y composición para tratar hipertensión ocular y glaucoma
AR067438A1 (es) Mejora de los sistemas de radiacion optica que se emplean en los tratamientos dermatologicos
MX2007000611A (es) Tratamiento de la piel con luz y un agente benefico para mitigar el acne.
GB201321053D0 (en) Phototherapy system
BRPI0910724A2 (pt) Dispositivos e método para tratamento endoluminal de vaso sanguíneo
WO2007146101A3 (en) Continuous low irradiance photodynamic therapy system and method
MX2009013031A (es) Método para producir un catalizador recubierto y un catalizador recubierto correspondiente.
UY31816A (es) Agente para el tratamiento y/o prevención de una enfemedad autoinmune y para la formación de células t reguladoras
WO2012076296A3 (de) Leuchtvorrichtung
WO2007016287A3 (en) Pdt treatment method for cellulites and cosmetic use
CR8637A (es) Punto substancial de alineacion ligera dentro de un reflector
AR073204A1 (es) Tratamientos de bananas.
CL2009001193A1 (es) Escaner biometrico para identificar a una persona que comprende fuentes de luz y medios para obtener el mapa vascular de la palma de una mano de la persona a identificar a partir de una radiacion de una longitud de onda predeterminada generada por las fuentes de luz; y procedimiento asociado.
BR112014027439A2 (pt) sistema para lipólise minimamente invasiva em uma área-alvo, método fototérmico de remoção de gordura in vivo, método para induzir o enrijecimento de pele em torno de regiões das quais o tecido adiposo foi removido, agente fototérmico para derreter a gordura e enrijecer a pele, e kit para a remoção fototérmica de gordura in vivo em uma área-alvo irradiada por energia de luz de nir
WO2013050589A3 (de) Strahlungsquelle sowie lichtleiteinrichtung
MX2013011600A (es) Metodo y aparato para ventana de iluminacion en estado solido mediante un diodo organico emisor de luz con emision de un lado, por lo menos parcialmente transparente.
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
CO6341583A2 (es) Catalizador para la descomposición de lignina, método para la preparación de alcoholes y ácidos orgánicos, método para la preparación de productos de la descomposición de lignina, catalizador para la descomposición de hidrocarburos aromáticos, método
WO2008122915A3 (en) Lighting structure
WO2012076294A3 (de) Leuchtvorrichtung
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad

Legal Events

Date Code Title Description
FB Suspension of granting procedure